MSM launches first prototype of Megastar Millionaire platform

|

Published 02-MAY-2016 16:37 P.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

MSM Corporation today announced that it had successfully achieved a prototype version of its online talent competition, Megastar Millionaire.

The creation of the prototype has come ahead of schedule and contains the basic features and functionalities that will distinguish the contest.

A limited invitation only audience can now log-in and utilise the platform in the same way that competition talent and fans will be able to when the competition has launched.

The data received from this audience will be used for qualitative research including market definition.

A highlight of the prototype is the ability of Megastar Millionaire’s talent and fans to link the platform app top a video player account (such as YouTube) and choose to share videos as well as vote on them.

The final product will also enable visitors to share content via social media platforms.

“The completion of our prototype marks a major milestone for MSM, as we continue to move towards the launch of the Megastar Millionaire platform,” said Managing Director Dion Sullivan.

“The initial version of the product will help us test product decisions and refine our platform, as well as engage strategic partners and attract potential competition contestants.”

In further news, MSM has appointed leading Australian media executive Sophie McGill as Executive Director on the Board of MSM, with immediate effect.

Ms. McGill who will take up the role on a part-time basis will focus on investor relations, promotional strategy and corporate development.

She has extensive experience and networks across the Australian media industry and was as Chief Operating Officer of Marquee Studios, a digital production and talent studio that helps brands build and engage an audience. At Marquee Studios, she worked with a number of well-known brands including Twitter, Rimmel London, UBK, Dolly, Coca Cola, Spotify and Mirvac.

Marquee is responsible for the tween media sensation Amplify Live, which tours global digital influencers around Australia in a stage show – trending globally and achieving a top spot in Australia’s music trending charts.

Ms. McGill has also held roles at Southern Star and its parent company, Endemol UK, one of the UK’s largest independent production companies. At Endemol she was responsible for delivering brand extensions of popular programs, including Big Brother, The Match and Deal or No Deal to a variety of digital platforms, including mobile and the web.

“MegaStar Millionaire is an excellent fusion of proven television formats, gaming techniques and hugely successful online platforms,” Ms. McGill said.

“The dynamics of the team creates the perfect storm to disrupt a constantly evolving market. My skill set feels complimentary amongst this team who I know can deliver results.”

The launch of the Megastar Millionaire platform remains on track for early 2017.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X